Skip to main content
SpringerLink
Log in
Book cover

Physikalische Therapiemaßnahmen in der Dermatologie pp 111–117Cite as

Strahlentherapie kutaner Lymphome

  • Chapter

  • 55 Accesses

Zusammenfassung

Kutane Lymphome gehören zur Gruppe der extranodalen Non-Hodgkin-Lymphome, innerhalb derer sie die zweithäufigste Lymphomform darstellen. Die Inzidenz wird auf eine Neuerkrankung pro Jahr und 100000 Einwohner geschätzt [28]. Primäre kutane Lymphome entstehen definitionsgemäß in der Haut und bleiben in der Regel über längere Zeit (mindestens 6 Monate) auf das Hautorgan beschränkt, während sekundäre kutane Lymphome kutane Manifestationen von disseminierten, primär nodalen oder extranodalen Lymphomen darstellen [29]. Primäre kutane Lymphome umfassen ein weites, klinisch und histologisch heterogenes Spektrum lymphoproliferativer Neoplasien, wobei 65% der kutanen Lymphome den kutanen T-Zell-Lymphomen (CTCL), 25% den kutanen B-Zell-Lymphomen (CBCL) und 10% weiteren, seltenen Formen von kutanen Lymphome zugeordnet werden können.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agnarsson BA, Vonderheid EC, Kadin ME (1990) Cutaneous T cell lymphoma with suppressor/cyto-toxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 22:569–577

    Article  PubMed  CAS  Google Scholar 

  2. Bauch B, Barraud-Klenowssek M, Burg G, Dummer R (1995) Eindrucksvolle Remission einer Mycosis fungoides im Tumorstadium unter low-dose Interferon-α und Acitretin nach erfolgloser Chemotherapie. Z Hautkr 70:200–203

    Google Scholar 

  3. Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, Meijer CJ, Willemze R (2000) Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95:3653–3661

    PubMed  CAS  Google Scholar 

  4. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R (1999) Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 155:483–492

    Article  PubMed  CAS  Google Scholar 

  5. Burg G, Hess M, Küng E, Dommann S, Dummer R (1994) Semimalignant („pseudolymphomatous“) cutaneous B-cell lymphomas. Dermatol Clin 12:399–407

    PubMed  CAS  Google Scholar 

  6. Cerroni L, Zochling N, Putz B, Kerl H (1997) Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 24:457–461

    Article  PubMed  CAS  Google Scholar 

  7. Chinn DM, Chow S, Kim YH, Hoppe RT (1999) Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Int J Radiat Oncol Biol Phys 43:951–958

    Article  PubMed  CAS  Google Scholar 

  8. Dummer R, Häffner AC, Hess M, Burg G (1996) A rational approach to the therapy of cutaneous T-cell lymphomas. Onkologie 19:226–230

    Article  Google Scholar 

  9. Dummer R, Willers J, Kamarashev J, Urosevic M, Döbbeling U, Burg G (2000) Pathogenesis of cutaneous lymphomas. Semin Cutan Med Surg 19:78–86

    Article  PubMed  CAS  Google Scholar 

  10. Dummer R, Kamarashev J, Kempf W, Haffner AC, Hess-Schmid M, Burg G (2002) Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol 138:199–203

    Article  PubMed  Google Scholar 

  11. Goldschmidt H, Lukacs S, Schoefìnius HH (1978) Teleroentgen therapy for mycosis fungoides. J Dermatol Surg Oncol 4:600–605

    PubMed  CAS  Google Scholar 

  12. Goldschmidt H (1991) Radiation therapy of other cutaneous tumors. In: Panizzon R (ed) Modern Dermatologic Radiation Therapy. Springer, Berlin, pp 123–132

    Chapter  Google Scholar 

  13. Grange F, Bekkenk MW, Wechsler J, Meijer CJ, Cerroni L, Bernengo M, Bosq J, Hedelin G, Fink Puches R, van Vloten WA, Joly P, Bagot M, Willemze R (2001) Prognostic factors in primary cutaneous large B-cell lymphomas: a European multi-center study. J Clin Oncol 19:3602–3610

    CAS  Google Scholar 

  14. Hoppe RT, Wood GS, Abel EA (1990) Mycosis fun-goides and the Sèzary syndrome: pathology, staging, and treatment. Curr Probi Cancer 14:293–371

    CAS  Google Scholar 

  15. Jones GW, Tadros A, Hodson DI, Rosenthal D, Roberts J, Thorson B (1994) Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 Gy. Int J Radiat Oncol Biol Phys 28:839–845

    Article  PubMed  CAS  Google Scholar 

  16. Jones GW, Hoppe RT, Glatstein E (1995) Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 9:1057–1076

    PubMed  CAS  Google Scholar 

  17. Jones GW, Wilson LD (1997) Mycosis fungoides and total skin electron beam radiation. Blood 89:3062–3064

    PubMed  CAS  Google Scholar 

  18. Kaye FJ, Bunn PJ, Steinberg SM, Stocker JL, Ihde DC, Fischmann AB, Glatstein EJ, Schechter GP, Phelps RM, Foss FM, Parlette H, Anderson M, Sausville E (1989) A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 321: 1784–1790

    Article  PubMed  CAS  Google Scholar 

  19. Kempf W, Dummer R, Burg G (1999) Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Am J Clin Pathol 111:84–93

    Google Scholar 

  20. Kim YH, Chow S, Varghese A, Hoppe RT (1999) Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 135:26–32

    Article  PubMed  CAS  Google Scholar 

  21. Kirova YM, Piedbois Y, Le Bourgeois JP (1999) Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases. Radiother Oncol 52:15–18

    Article  PubMed  CAS  Google Scholar 

  22. Kirova YM, Piedbois Y, Pan Q, Guo L, Le Bourgeois JP (1999) Radiotherapie des lymphomes cutanes. Cancer Radiother 3:105–111

    Article  PubMed  CAS  Google Scholar 

  23. Micaily B, Campbell O, Moser C, Vonderheid EC, Brady LW (1991) Total skin electron beam and total nodal irradiation of cutaneous T-cell lymphoma. Int J Radiat Oncol, Biol, Phys 20:809–813

    Article  CAS  Google Scholar 

  24. Savoia P, Fierro MT, Novelli M, Quaglino P, Verrone A, Geuna M, Bernengo MG (1997) CD56-po-sitive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease. Br J Dermatol 137:966–971

    Article  PubMed  CAS  Google Scholar 

  25. Schirren CG (1955) Roentgen irradiation at a distance using soft radiation at a distance, using soft radiation from beryllium-window tubes. J Invest Dermatol 24:463–467

    Article  PubMed  CAS  Google Scholar 

  26. Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, Olsen E, Pittelkow M, Russell-Jones R, Takigawa M, Willemze R (2002) Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46:95–106

    Article  PubMed  Google Scholar 

  27. Voss N, Kim Sing C (1998) Radiotherapy in the treatment of dermatologic malignancies. Dermatol Clin 16:313–320

    Article  PubMed  CAS  Google Scholar 

  28. Weinstock MA (1994) Epidemiology of mycosis fungoides. Semin Dermatol 13:154–159

    PubMed  CAS  Google Scholar 

  29. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354–371

    PubMed  CAS  Google Scholar 

  30. Wiskemann A, Buck C (1978) Radiotherapy of mycosis fungoides: twenty years of experience with teleroentgen and low-voltage X-ray therapy. J Dermatol Surg Oncol 4:606–610

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Dummer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Burg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dermatologische Klinik, Universitätsspital Zürich, Gloriastraße 31, 8091, Zürich, Schweiz

    Reinhard Dummer

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dummer, R., Burg, G. (2003). Strahlentherapie kutaner Lymphome. In: Dummer, R. (eds) Physikalische Therapiemaßnahmen in der Dermatologie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-12704-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12704-9_18

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-12705-6

  • Online ISBN: 978-3-662-12704-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation